Study
|
Country
|
Ethnicity
|
Disease
|
Control Source
|
Genotyping Methods
|
Sample Size Cases/Controls
|
Genotype Distribution
|
PHWE
|
NOS
|
---|
Cases
|
Controls
|
---|
rs699947
| | | | | | |
AA/AC/CC
|
AA/AC/CC
| | |
Biselli 200823
|
Brazil
|
Caucasian
|
CAD
|
HB
|
PCR
|
175/108
|
32/96/47
|
27/51/30
|
0.569
|
6
|
Kangas–Kontio 200925
|
Finland
|
Caucasian
|
MI
|
HB
|
TaqMan
|
188/218
|
64/87/37
|
77/101/40
|
0.498
|
7
|
Chen 201126
|
UK
|
Caucasian
|
MI
|
PB
|
PCR–RFLP
|
46/372
|
10/34/2
|
100/167/105
|
0.050
|
8
|
Amoli 201227
|
Iran
|
Asian
|
CAD
|
HB
|
PCR
|
50/50
|
9/26/15
|
14/27/9
|
0.520
|
6
|
Cui 201328
|
China
|
Asian
|
CAD
|
HB
|
PCR
|
242/253
|
27/78/137
|
12/69/172
|
0.148
|
6
|
Gu 201329
|
China
|
Asian
|
CAD
|
HB
|
MassARRAY
|
427/472
|
30/178/219
|
31/174/267
|
0.713
|
6
|
Li 201622
|
China
|
Asian
|
CAD
|
PB
|
PCR
|
533/533
|
180/250/103
|
217/237/79
|
0.280
|
8
|
Liu 201631
|
China
|
Asian
|
CAD
|
PB
|
PCR
|
810/805
|
275/381/154
|
339/345/121
|
0.03
|
8
|
rs2010963
| | | | | | |
GG/GC/CC
|
GG/GC/CC
| | |
Petrovic 200724
|
Slovenia
|
Caucasian
|
MI
|
PB
|
PCR
|
143/228
|
42/76/25
|
103/104/21
|
0.470
|
7
|
Kangas–Kontio 200925
|
Finland
|
Caucasian
|
MI
|
HB
|
TaqMan
|
186/218
|
113/61/12
|
143/67/8
|
0.966
|
7
|
Chen 201126
|
UK
|
Caucasian
|
MI
|
PB
|
PCR–RFLP
|
46/372
|
26/19/1
|
174/159/39
|
0.765
|
8
|
Cui 201328
|
China
|
Asian
|
CAD
|
HB
|
PCR
|
242/253
|
75/102/65
|
104/114/35
|
0.675
|
6
|
Gu 201329
|
China
|
Asian
|
CAD
|
HB
|
MassARRAY
|
419/468
|
144/215/60
|
154/225/89
|
0.672
|
6
|
Douvaras 201332
|
Greece
|
Caucasian
|
MI
|
HB
|
PCR–RFLP
|
102/98
|
37/49/16
|
29/55/14
|
> 0.050
|
7
|
Moradzadegan 201530
|
Iran
|
Asian
|
CAD
|
HB
|
PCR–RFLP
|
141/369
|
43/65/33
|
85/197/87
|
0.193
|
7
|
Han 201521
|
China
|
Asian
|
CAD
|
HB
|
MassARRAY
|
144/150
|
69/49/26
|
86/54/10
|
0.701
|
6
|
Li 201622
|
China
|
Asian
|
CAD
|
PB
|
PCR
|
533/533
|
50/233/250
|
71/239/223
|
0.583
|
8
|
Nia 201733
|
Iran
|
Asian
|
CAD
|
HB
|
TaqMan
|
347/173
|
167/135/45
|
102/63/8
|
> 0.050
|
7
|
rs3025039
| | | | | | |
CC/CT/TT
|
CC/CT/TT
| | |
Biselli 200823
|
Brazil
|
Caucasian
|
CAD
|
HB
|
PCR
|
175/108
|
133/36/6
|
83/23/2
|
0.783
|
6
|
Kangas–Kontio 200925
|
Finland
|
Caucasian
|
MI
|
HB
|
TaqMan
|
187/218
|
140/42/5
|
155/56/7
|
0.488
|
7
|
Chen 201126
|
UK
|
Caucasian
|
MI
|
PB
|
PCR–RFLP
|
46/372
|
37/8/1
|
264/95/13
|
0.229
|
8
|
Cui 201328
|
China
|
Asian
|
CAD
|
HB
|
PCR
|
242/253
|
133/95/14
|
159/86/8
|
0.373
|
6
|
Gu 201329
|
China
|
Asian
|
CAD
|
HB
|
MassARRAY
|
430/473
|
272/142/16
|
300/159/14
|
0.194
|
6
|
Douvaras 201332
|
Greece
|
Caucasian
|
MI
|
HB
|
PCR–RFLP
|
102/98
|
68/30/4
|
69/27/2
|
> 0.050
|
7
|
Han 201521
|
China
|
Asian
|
CAD
|
HB
|
MassARRAY
|
144/150
|
84/55/5
|
115/31/4
|
0.290
|
6
|
Liu 201631
|
China
|
Asian
|
CAD
|
PB
|
PCR
|
810/805
|
472/308/30
|
617/167/21
|
0.020
|
8
|
rs1570360
| | | | | | |
GG/GA/AA
|
GG/GA/AA
| | |
Biselli 200823
|
Brazil
|
Caucasian
|
CAD
|
HB
|
PCR
|
175/108
|
96/61/18
|
57/38/13
|
0.104
|
6
|
Cui 201328
|
China
|
Asian
|
CAD
|
HB
|
PCR
|
242/253
|
151/79/12
|
172/69/12
|
0.148
|
6
|
Liu 201631
|
China
|
Asian
|
CAD
|
PB
|
PCR
|
810/805
|
54/370/386
|
137/456/212
|
> 0.050
|
8
|
- Abbreviations: CAD coronary artery disease; MI myocardial infarction; PCR polymerase chain reaction; PCR–RFLP polymerase chain reaction-restriction fragment length polymorphism; HWE Hardy–Weinberg equilibrium; PB population–based; HB hospital–based; NOS Newcastle–Ottawa quality scale; UK the United Kingdom